Incorporated in 2015, Mumbai-based Rajnish Wellness Limited is a company engaged in the business of selling various products in categories ranging from consumer durables to ayurvedic personal care products. The Company's major focus area is sexual wellness, energy revitalization, and personal care products.[1]
History[1]Rajnish Wellness is the extension and expansion of Rajnish Hot Deal Pvt Ltd. Co. started as a small teleshopping venture with the name- Quick Service (QS) Advertising in 2009 and has grown into a brand in ayurvedic product industry dedicated to people’s personal and sexual wellness.
| S.No. | Name | Current Price (Rs.) | Price to Earning | Market Capitalization (Rs.Cr.) | Dividend yield (%) | Net Profit latest quarter (Rs.Cr.) | YOY Quarterly profit growth (%) | Sales latest quarter (Rs.Cr.) | YOY Quarterly sales growth (%) | Return on capital employed (%) | Sales (Rs.Cr.) | OPM (%) | Profit after tax (Rs.Cr.) | Profit after tax latest quarter (Rs.Cr.) | Price to book value | Return on assets (%) | Debt to equity |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | Sun Pharma.Inds. | 1760.20 | 36.58 | 422330.94 | 0.91 | 3124.95 | 2.56 | 14478.31 | 8.93 | 20.21 | 54964.01 | 30.12 | 11543.96 | 3117.95 | 5.43 | 12.97 | 0.07 |
| 2. | Divi's Lab. | 6642.50 | 70.96 | 176337.50 | 0.45 | 689.00 | 35.10 | 2715.00 | 16.12 | 20.44 | 10029.00 | 32.37 | 2485.00 | 689.00 | 11.44 | 13.53 | 0.01 |
| 3. | Torrent Pharma. | 3936.80 | 61.50 | 133239.20 | 0.81 | 591.00 | 32.49 | 3302.00 | 14.30 | 27.05 | 12248.00 | 32.60 | 2166.53 | 600.17 | 15.77 | 13.26 | 0.33 |
| 4. | Cipla | 1530.80 | 22.73 | 123653.62 | 0.85 | 1353.37 | 3.73 | 7589.44 | 7.64 | 22.72 | 28349.57 | 25.40 | 5441.14 | 1351.17 | 3.76 | 14.72 | 0.01 |
| 5. | Dr Reddy's Labs | 1256.20 | 18.16 | 104846.27 | 0.64 | 1336.80 | 7.28 | 8828.30 | 9.83 | 22.69 | 34310.00 | 24.64 | 5772.20 | 1347.10 | 2.91 | 12.95 | 0.16 |
| 6. | Lupin | 2149.70 | 22.71 | 98198.04 | 0.56 | 1484.83 | 73.34 | 7047.51 | 24.23 | 21.30 | 24750.69 | 27.25 | 4324.63 | 1477.92 | 5.00 | 12.41 | 0.32 |
| 7. | Zydus Lifesci. | 931.05 | 18.63 | 93685.42 | 1.18 | 1238.60 | 40.92 | 6123.20 | 16.92 | 24.31 | 24493.90 | 31.10 | 5029.35 | 1283.60 | 3.70 | 14.64 | 0.38 |
| 8. | Rajnish Wellness | 0.57 | – | 57.87 | 0.00 | 0.06 | -78.57 | 12.00 | -31.11 | 0.59 | 31.39 | -1.66 | -0.11 | 0.06 | 0.53 | 0.17 | 0.00 |
| – | Median: 151 Co. | 405.75 | 30.68 | 1679.94 | 0.11 | 12.57 | 11.71 | 152.64 | 10.58 | 14.89 | 574.01 | 15.93 | 43.84 | 13.49 | 3.11 | 8.56 | 0.22 |
Standalone figures in ₹ crores
| Dec 2022 | Dec 2023 | Dec 2024 | Jun 2023 | Jun 2024 | Jun 2025 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 7.87 | 21.62 | 9.06 | 8.51 | 16.30 | 4.56 | 5.71 | 26.98 | 5.77 | 6.74 | 18.51 | 17.42 | 12.00 |
Expenses | 7.92 | 21.33 | 8.92 | 8.48 | 16.29 | 4.39 | 7.16 | 26.44 | 6.38 | 6.62 | 18.47 | 16.94 | 12.22 |
Operating Profit | -0.05 | 0.29 | 0.14 | 0.03 | 0.01 | 0.17 | -1.45 | 0.54 | -0.61 | 0.12 | 0.04 | 0.48 | -0.22 |
Other Income | 0.57 | -0.00 | 0.01 | 0.83 | 0.35 | 0.12 | 0.65 | -0.00 | 0.16 | 0.13 | 0.23 | -0.00 | 0.31 |
Profit before tax | 0.51 | 0.17 | 0.10 | 0.73 | 0.23 | 0.29 | -0.99 | 0.42 | -0.46 | 0.21 | 0.13 | 0.37 | 0.09 |
Tax % | 25.49% | 35.29% | 20.00% | 24.66% | 26.09% | 27.59% | 17.17% | 30.95% | -0.00% | 23.81% | 23.08% | 24.32% | 22.22% |
Net Profit | 0.38 | 0.10 | 0.07 | 0.55 | 0.17 | 0.22 | -1.16 | 0.28 | -0.46 | 0.16 | 0.10 | 0.28 | 0.06 |
EPS in Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Standalone Figures in ₹ Crores / Yearly
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
Sales | 25.22 | 27.50 | 41.67 | 13.75 | 13.34 | 26.44 | 25.72 | 76.68 | 48.56 | 31.39 |
Expenses | 24.03 | 24.20 | 35.15 | 13.61 | 16.51 | 26.63 | 26.83 | 74.69 | 48.55 | 31.91 |
Operating Profit | 1.19 | 3.30 | 6.52 | 0.14 | -3.17 | -0.19 | -1.11 | 1.99 | 0.01 | -0.52 |
Other Income | -0.00 | 1.15 | 0.29 | 0.19 | 3.64 | 0.94 | 1.79 | -0.00 | 0.52 | 0.60 |
Interest | 0.23 | 0.76 | 0.88 | 0.89 | 0.30 | 0.28 | 0.04 | 0.52 | 0.27 | 0.04 |
Depreciation | 0.01 | 0.05 | 0.06 | 0.05 | 0.06 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 |
Profit before tax | 0.95 | 3.64 | 5.87 | -0.61 | 0.11 | 0.46 | 0.63 | 1.45 | 0.24 | 0.02 |
Net Profit | 0.64 | 2.43 | 4.23 | -0.61 | 0.10 | 0.39 | 0.46 | 1.03 | 0.17 | -0.11 |
EPS in Rs | 0.94 | 0.06 | 0.08 | -0.01 | 0.00 | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 |
Dividend Payout % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | – |
Standalone figures in ₹ crores
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 0.05 | 3.41 | 4.67 | 4.67 | 4.67 | 10.52 | 76.85 | 76.85 | 76.85 | 101.53 |
Reserves | 0.96 | 2.61 | 17.56 | 16.95 | 17.05 | 11.60 | 6.13 | 7.14 | 7.31 | 7.59 |
Borrowings | 2.74 | 3.81 | 4.66 | 7.71 | -0.00 | -0.00 | 10.18 | 4.92 | 0.18 | -0.00 |
Other Liabilities | 4.63 | 7.77 | 4.82 | 3.81 | 12.81 | 12.99 | 5.74 | 17.35 | 6.94 | 12.19 |
Total Liabilities | 8.38 | 17.60 | 31.71 | 33.14 | 34.53 | 35.11 | 98.90 | 106.26 | 91.28 | 121.31 |
Fixed Assets | 0.05 | 0.10 | 0.11 | 0.06 | -0.00 | 0.03 | 0.05 | 0.06 | 0.05 | 0.04 |
Gross Block | 0.06 | 0.17 | 0.24 | 0.24 | 0.24 | 0.27 | 0.30 | 0.20 | 0.21 | – |
Accumulated Depreciation | 0.02 | 0.07 | 0.13 | 0.18 | 0.24 | 0.25 | 0.26 | 0.14 | 0.16 | – |
CWIP | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
Investments | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 3.31 | 17.80 |
Other Assets | 8.33 | 17.50 | 31.60 | 33.08 | 34.53 | 35.08 | 98.85 | 106.20 | 87.92 | 103.47 |
Total Assets | 8.38 | 17.60 | 31.71 | 33.14 | 34.53 | 35.11 | 98.90 | 106.26 | 91.28 | 121.31 |
Standalone Figures in ₹ Crores / Yearly
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|
Cash from Operating Activity | -1.67 | -3.23 | -8.98 | -6.51 | 0.09 | -0.01 | -62.08 | 1.70 | -4.25 |
Cash from Investing Activity | -0.04 | -0.11 | -0.07 | -0.00 | -0.00 | -0.03 | -0.03 | -0.04 | 9.34 |
Cash from Financing Activity | 1.31 | 3.30 | 10.47 | 5.05 | -0.03 | 0.78 | 61.54 | -1.77 | -4.93 |
Net Cash Flow | -0.40 | -0.04 | 1.41 | -1.46 | 0.06 | 0.74 | -0.57 | -0.11 | 0.16 |
Standalone Figures in ₹ Crores / Yearly
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 59.34 | 181.70 | 163.97 | 318.28 | 459.67 | 223.64 | 286.52 | 160.22 | 200.61 |
Inventory Days | 151.87 | 74.91 | 77.48 | 47.93 | 26.57 | 31.95 | 59.23 | 47.64 | 78.78 |
Days Payable | 120.80 | 145.22 | 27.41 | 55.76 | 50.49 | 17.19 | 55.28 | 77.50 | 30.57 |
Cash Conversion Cycle | 90.40 | 111.39 | 214.05 | 310.45 | 435.76 | 238.40 | 290.47 | 130.36 | 248.82 |
Working Capital Days | 29.96 | 102.47 | 182.98 | 702.13 | 791.02 | 406.55 | 448.87 | 305.12 | 529.61 |
ROCE % | – | 64.80% | 36.76% | 1.00% | 1.61% | 3.38% | 1.16% | 2.16% | 0.59% |
Direct from BSE filings, auto-summarised
External media mentions & references
Editorial & research coverage
No credit ratings.
Stock Analysis
Rajnish Wellness Limited, established in 2015 and based in Mumbai, operates in the consumer durables and ayurvedic personal care sectors, with a strategic focus on sexual wellness, energy revitalization, and personal care products.
The company has been expanding its 'Dava Discount' medical franchise network, with recent openings in Kerala, Assam, and West Bengal, aiming to strengthen its pharmaceutical and healthcare distribution footprint.
Currently no data available for Order Book.
Recent financial performance indicates a downturn with significant YoY declines in revenue and net profit. Concerns also exist regarding the low utilization of rights issue funds and a substantial decrease in promoter shareholding, along with historically low ROE and high debtor days.
Currently no data available for Key Dates To Watch.
Corporate Announcements
